SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3236VTL -77%/Friday-AH on phase-3 failure of ELAD system in alcohol-induced liver diDewDiligence_on_SI-8/22/2015
3235OPHT -17% at day's low, closed -11% on 5 X ADV. This follows two strongly dotnsaf-8/7/2015
3234ACAD, off 15%. Downgrade by Piper, PT raise (to 49 and 50, respectively) by Neescaram(o)uche-8/7/2015
3233BLUE, off 16% on no news. Wow.scaram(o)uche-8/7/2015
3232SGMO down 19% on earnings release [graphic]The Ox-8/6/2015
3231SRNE -19% at the day's low; closed -13%tnsaf-7/28/2015
3230Some believe that chronic pot smokers don't have much of an issue with lung scaram(o)uche-7/28/2015
3229IMMU down >39% in Pre-Market. Not sure about the cause.<g> But the stocJibacoa-7/28/2015
3228Corbus Pharma (CRBP) off 18% - near 52 week lows - on somewhat heavy volume and tuck-7/27/2015
3227BioLineRx (BLRX) Announces Top-Line Results from Bellerophon’s PRESERVATION I ClJulius Wong-7/27/2015
3226BIiB -22% - Biogen Shares Plunge 22% on Poor MS Drug Performance, Slashed Outlootnsaf-7/24/2015
3225FDA tells Sunesis that more clinical evidence needed before filing for vosaroxinJulius Wong-7/23/2015
3224XOMA Announces Results From Phase 3 EYEGUARD(TM)-B Study finance.yahoo.comJulius Wong-7/22/2015
3223Why Esperion Shares Are Down 18% Today Matthew HerperForbes Staff Shares of Esptnsaf16/10/2015
3222GBIM down 51% on 49x avg volume. Gilead-GlobeImmune Hepatitis B Drug Fails TrialJulius Wong-5/27/2015
3221PBMD down >26.40% in preMarket trading. Apparently on profit taking after yesJibacoa-5/21/2015
3220LTPN -78% on failure of AMD program: siliconinvestor.comDewDiligence_on_SI-5/20/2015
3219OT. Re: DEPO's possible comeback.<g> Yes, I am aware of Jason's oJibacoa-5/13/2015
3218Re: DEPO: Jason Napodano makes the case that this sell-off is a buying op. Thituck-5/13/2015
3217DEPO down > 16% after reporting 1stQ results yesterday. <g> Volume willJibacoa-5/12/2015
3216AGTC & ONCE on news from the University of Pennsylvania some prominent investnsaf-5/5/2015
3215ACRX AH off 25% Probably their PR... AcelRx reports Q1 earnings, provides ZalIan@SI-5/4/2015
3214Certainly doesn't have the meaning of old days, and I'm not really certascaram(o)uche-4/28/2015
3213Clearly a shorts piling on play. Over 30 stocks in my bio lists are marked as lThe Ox-4/28/2015
3212I would wait for a sign to catch knives. I tried yday with 1-2 big caps and got Robohogs-4/28/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News